Shanghai Haohai Biological (06826) Announces Share Repurchase Update

Bulletin Express
Nov 12

Shanghai Haohai Biological Technology Co., Ltd. (06826) released a Next Day Disclosure Return, highlighting no changes in its total issued H shares. As of 12 November 2025, the number of issued H shares (excluding treasury shares) remained at 38,529,240.

Meanwhile, the company maintains 190,203,760 issued A shares and 3,848,095 treasury A shares, for a total of 194,051,855 A shares. No additional changes to A shares or treasury A shares were reported as of 12 November 2025.

The return also revealed multiple repurchase transactions associated with H shares that have yet to be canceled, covering buybacks made between 15 September 2025 and 12 November 2025. On 12 November 2025, 22,000 H shares were repurchased at a highest price of HKD 28.1 and a lowest price of HKD 27.96, with an aggregate price of HKD 617,844. The company’s board confirms that all repurchases complied with applicable listing rules and regulations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10